Skip to content

The assessment of effectiveness of respiratory muscle training (I M T)and aerobic training in patients with pulmonary disease

The assessment of effectiveness of respiratory muscle training (I M T)and aerobic training on quality of life in patients with chronic obstructive pulmonary disease(C O P D)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180205038633N1
Enrollment
68
Registered
2019-03-17
Start date
2017-03-21
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic bronchitis-emphysema. Emphysema Excl.: emphysema-Simple and mucopurulent chronic bronchitis

Interventions

Intervention 1: Intervention group: Intervention group: -. Intervention 2: ?Exercise group and respiratory training. Intervention 3: Intervention group: Respiratory training group. Intervention 4: Co

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Satisfaction to participate in the study Getting Grade 2 or 3 Based on GOLD Criteria Age 40 to 70 years Failure to have previous known disease, such as heart disease (such as C.H.F and coronary artery disease), or disease of the lungs (E.S.R.D and C.R.F), and liver (cirrhosis of the liver, cancer, etc.) Lack of other pulmonary diseases, such as lung cancer, plural disease, or musculature involvement. The lack of extreme limbs that prevent aerobic exercise Lack of pulmonary surgery in the last 12 months Recent fracture failure at the level of ribs (6 months) No history of psychotropic disease and related drugs and alcohol and psychotropic substances

Exclusion criteria

Exclusion criteria: Failure to have previous known disease, such as heart disease (such as C.H.F and coronary artery disease), or disease of the lungs (E.S.R.D and C.R.F), and liver (cirrhosis of the liver, cancer, etc.)

Design outcomes

Primary

MeasureTime frame
Spirometric FEV 1 Index - Quality of Life Indicator score. Timepoint: Beginning of study - Week 4 - Week 8. Method of measurement: Lung Spirometry - St. George's Quality of Life Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr amirhosseion abedi yekta

Shahid Beheshti University of Medical Sciences

Abedi_yekta@yahoo.com021230311 - 02122432560-9

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026